Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05479786
Other study ID # ECTO-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2012
Est. completion date December 31, 2020

Study information

Verified date July 2022
Source University of Palermo
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Although ectopic pregnancy was considered a leading cause of first-trimester maternal mortalities, current technological improvements allowed early diagnosis and opened a door for applying less invasive approaches. A tubal pregnancy could be managed either expectantly, medically, or surgically. The expectant management of ectopic pregnancy relies on the fact that a considerable proportion of ectopic gestations terminate by spontaneous tubal abortion. This approach is usually kept for stable cases with a small gestational sac and low beta-human chorionic gonadotropin (beta-HCG) serum levels. For hemodynamically unstable patients, higher levels of beta-HCG, and larger gestational sacs, surgery is often considered as the treatment of choice (16). Considering this background, the study aims to analyze the subsequent natural reproductive outcomes of patients that had a previous tubal ectopic pregnancy and were managed either expectantly or surgically. Moreover, it amis to determine the factors that could influence the fertility potential of these patients in each treatment group.


Recruitment information / eligibility

Status Completed
Enrollment 312
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Women with one episode of tubal ectopic pregnancy, treated by expectant management, salpingectomy, or salpingostomy; - For patients treated surgically, only patients with at least one patent Fallopian tube confirmed via postoperative hysterosalpingography were included in the analysis. Exclusion Criteria: - Pregnancies of unknown location - Other types of ectopic pregnancy - Pelvic inflammatory disease - Pelvic adhesions - Intrauterine pathologies - Pregnancies obtained after assisted-reproductive technologies (ART)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Expectant management
Follow-up with beta-HCG dosages and transvaginal ultrasound scans
Procedure:
Salpingectomy
Removal of the affected Fallopian tube by laparoscopy
Salpingostomy
Removal of the ectopic pregnancy from the Fallopian tube, without removing the whole Fallopian tube, by laparoscopy

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University of Palermo Damascus University, University of Debrecen

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy rate Presence of a gestational sac under ultrasonography Within one year after the previous episode of tubal ectopic pregnancy
See also
  Status Clinical Trial Phase
Completed NCT02995356 - Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy
Completed NCT01876004 - Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Phase 4
Not yet recruiting NCT05039853 - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task N/A
Completed NCT00194207 - Risk Factors of Ectopic Pregnancy N/A
Completed NCT00827970 - Randomized Population-Based Study on Chlamydia Trachomatis Screening N/A
Recruiting NCT05374720 - Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy N/A
Completed NCT03894735 - Vitamin D in Ectopic Pregnancies
Recruiting NCT01860690 - BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success Phase 4
Recruiting NCT04176549 - Assessment of Biomarkers in Ectopic Pregnancy
Not yet recruiting NCT05890066 - Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy N/A
Completed NCT01855568 - Methotrexate Treatment for Ectopic Pregnancy Phase 3
Not yet recruiting NCT04308343 - The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy N/A
Recruiting NCT06354439 - Use of Letrozole for Ectopic Pregnancy Phase 4
Not yet recruiting NCT06300333 - Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
Completed NCT00194272 - Two-Dose Methotrexate for Ectopic Pregnancy Phase 3
Enrolling by invitation NCT03579550 - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus N/A
Completed NCT05446012 - Relationship Between Ectopic Pregnancy and Thyroid Disorders
Completed NCT00194168 - Ectopic Pregnancy Biomarkers N/A
Completed NCT02152696 - Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Phase 3
Not yet recruiting NCT04975984 - Expectant Management of Ectopic Pregnancy